Published in CRC Crit Rev Biochem on November 01, 1976
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Induction of an inhibitor of interferon action in a mouse lymphokine preparation. Infect Immun (1979) 1.03
Interferon production by Shigella flexneri-infected fibroblasts depends upon intracellular bacterial metabolism. Infect Immun (1990) 0.87
Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells. Clin Exp Immunol (1987) 0.75
Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med (1982) 5.33
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol (1983) 4.38
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol (1981) 4.04
Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01
Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol (1994) 2.99
Staphylococcal enterotoxin B: solid-phase radioimmunoassay. Appl Microbiol (1971) 2.69
Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int J Cancer (1966) 2.51
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature (1984) 2.18
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science (1968) 2.02
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest (1984) 2.00
Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99
Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation. J Bacteriol (1966) 1.96
The use of a wate-soluble carbodiimide as a coupling reagent in the passive hemagglutination test. J Immunol (1966) 1.94
Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect Immun (1979) 1.89
The effect of staphylococcal enterotoxins on the primary in vitro immune response. J Immunol (1975) 1.88
Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85
Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med (1972) 1.79
Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol (1982) 1.79
High interferon producing line of transformed murine cells. J Gen Virol (1972) 1.79
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis (1973) 1.70
Staphylococcal enterotoxins A and B: solid-phase radioimmunoassay in food. Appl Microbiol (1973) 1.66
Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Large-scale production and partial purification of mouse immune interferon. Infect Immun (1979) 1.57
Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003. Epidemiol Infect (2007) 1.54
Antigenic cross-reactivity of staphylococcal enterotoxins. Infect Immun (1972) 1.53
Long-term mortality profile of heavily-exposed lead smelter workers. J Occup Med (1982) 1.53
The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A (1965) 1.52
General considerations of the interferon system. Tex Rep Biol Med (1977) 1.52
Classification of interferons with antibody to immune interferon. Cell Immunol (1980) 1.49
IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.49
European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine (2003) 1.48
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med (1971) 1.47
The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol (1983) 1.46
Stability of 125I-labeled staphylococcal enterotoxins in solid-phase radioimmunoassay. Appl Microbiol (1975) 1.45
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci U S A (1982) 1.44
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42
Identification of a subpopulation of mouse lymphoid cells required for interferon production after stimulation with mitogens. J Immunol (1974) 1.41
Unexpectedly rapid action of human interferon in physiological conditions. Nature (1975) 1.41
Evaluation of an interferon inducer in viral respiratory disease. JAMA (1972) 1.37
Simple Eye Tests in a Pediatrician's Office: Their Value. Cal West Med (1937) 1.36
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature (1976) 1.35
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures. J Immunol (1982) 1.32
Interferon-induced transfer of viral resistance between animal cells. Nature (1977) 1.31
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene (2010) 1.31
Effect of interferon on early interferon production. Science (1966) 1.30
Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide. J Exp Med (1972) 1.30
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Sensitivity of common respiratory viruses to an interferon inducer in human cells. Lancet (1969) 1.29
Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol (1993) 1.27
Growth of Toxoplasma gondii in various tissue cultures treated with In-Cn or interferon. Proc Soc Exp Biol Med (1973) 1.26
Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. J Immunol (1989) 1.25
Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24
Characterization of the airborne concentrations of lead in U.S. industry. Am J Ind Med (1990) 1.23
Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23
Effects of interferon inducers on the intracellular growth of the protozoan parasite, Leishmania donovani. Nature (1970) 1.23
Enterotoxin B: serological assay in cultures by passive hemagglutination. Appl Microbiol (1967) 1.23
Hmx2 homeobox gene control of murine vestibular morphogenesis. Development (2001) 1.22
Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque. J Clin Microbiol (1976) 1.22
Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice. Proc Soc Exp Biol Med (1970) 1.22
The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol (1976) 1.21
Three strains of influenza A virus (H3N2): interferon sensitivity in vitro and interferon production in volunteers. J Clin Microbiol (1976) 1.21
Antiviral action of mouse interferon in heterologous cells. J Bacteriol (1966) 1.19
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus. Infect Immun (1975) 1.19
Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 1.19
Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. J Infect Dis (1980) 1.18
[Evaluation of tracheobronchial lesions with spiral CT: comparison between virtual endoscopy and bronchoscopy]. Radiol Med (2002) 1.17
Interleukin 2 enhances natural killing of normal lymphocytes. Cell Immunol (1984) 1.17
Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon. J Virol (1969) 1.16
IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis. J Immunol (1995) 1.16
Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex. Proc Natl Acad Sci U S A (1969) 1.14
Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst (1980) 1.14
Definition and classification of the interferons. Methods Enzymol (1981) 1.14
Leukotrienes: positive signals for regulation of gamma-interferon production. J Immunol (1984) 1.13
Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA. J Immunol (1992) 1.13
Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13
Differentiation of the immunosuppressive and antiviral effects of interferon. Cell Immunol (1978) 1.13
Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol (1982) 1.12
Broadly active inhibitor of viruses spontaneously produced by many cell types in culture. Infect Immun (1981) 1.12
Rubella virus: role of interferon during infection of African green monkey kidney tissue cultures. J Immunol (1967) 1.12
The effect of an interferon inducer on influenza virus. Bull World Health Organ (1969) 1.10
Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1991) 1.09
Interferon: lack of detectable uptake by cells. Science (1966) 1.09
So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine (2001) 1.08
Pesticide-related illness among migrant farm workers in the United States. Int J Occup Environ Health (2002) 1.07